Infinity Pharmaceuticals Inc expected to post a loss of 10 cents a share - Earnings Preview

Infinity Pharmaceuticals

28/04/2023 23:09

* Infinity Pharmaceuticals Inc  INFI.OQ   INFI.O  is
expected
to show a fall in quarterly revenue when it reports  results on
May 1 (estimated). 
    * The Cambridge Massachusetts-based  company is expected to
report
 a 54.0% decrease in revenue to $300 thousand from $652 thousand
a year ago, according to the mean estimate from 2 analysts,
based on Refinitiv data. 
    * ​Refinitiv's mean analyst estimate for Infinity
Pharmaceuticals
Inc is for a loss of 10 cents per share. 
    * The current average analyst rating on the shares is "hold"
and
the breakdown of recommendations is 1 "strong buy" or "buy," 2
"hold" and no "sell" or "strong sell."  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for Infinity
Pharmaceuticals Inc is $2.15​, above​ its last closing price
of $0.18. ​​​

This summary was machine generated April 28 at 22:09 GMT.  All
figures in US dollars  unless otherwise stated